...
首页> 外文期刊>International journal of molecular medicine >The effects of siRNA against RPL22 on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells
【24h】

The effects of siRNA against RPL22 on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells

机译:siRNA对抗RPL22对ET-1诱导的人肺动脉平滑肌细胞增殖的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to investigate the effects of small interference RNA (siRNA) against ribosomal protein L22 (RPL22) on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells (HPASMCs). HPASMCs were transfected with siRNA against RPL22, incubated in smooth muscle cell culture medium (SMCM) and ET-1. RPL22 gene expression and protein levels of HPASMCs were measured by real-time PCR and western blotting, respectively. PCNA, CCK-8 immunohistochemistry and flow cytometry analysis were used to evaluate HPASMC proliferation. Cyclin D1 (CCND1) expression was also assayed. Following transfection with siRNA against RPL22, RPL22 expression was significantly inhibited in the control and ET-1 groups. HPASMC proliferation was significantly suppressed by transfection with siRNA against RPL22. Moreover, CCND1 was also downregulated by inhibiting RPL22 expression. In conclusion, these data suggest that inhibition of RPL22 expression can suppress HPASMC proliferation and CCND1 expression. The effects of siRNA against RPL22 on HPASMC proliferation are considered to be mediated through inhibition of CCND1 expression.
机译:本研究的目的是研究针对核糖体蛋白L22(RPL22)的小干扰RNA(siRNA)对ET-1诱导的人肺动脉平滑肌细胞(HPASMC)增殖的影响。用针对RPL22的siRNA转染HPASMC,并在平滑肌细胞培养基(SMCM)和ET-1中孵育。分别通过实时PCR和蛋白质印迹法检测HPASMC的RPL22基因表达和蛋白水平。 PCNA,CCK-8免疫组化和流式细胞仪分析用于评估HPASMC增殖。还测定了细胞周期蛋白D1(CCND1)的表达。用针对RPL22的siRNA转染后,对照组和ET-1组的RPL22表达被显着抑制。用针对RPL22的siRNA转染可显着抑制HPASMC的增殖。此外,CCND1也通过抑制RPL22表达而下调。总之,这些数据表明抑制RPL22表达可以抑制HPASMC增殖和CCND1表达。 siRNA对抗RPL22对HPASMC增殖的影响被认为是通过抑制CCND1表达来介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号